Filed: 8/14/2023ACC: 0001315863-23-000705
📋 What this filing means
TWO SEAS CAPITAL LP filed this quarterly 13F‑HR report disclosing 13 equity positions with a total reported market value of $457.46M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
13
Positions
$457.46M
Total AUM (reported)
36.79M
Total Shares
Allocation by class
ORD$325.32M71.1%
SHS$79.73M17.4%
COM$28.14M6.2%
COM NEW$10.99M2.4%
CL A$8.61M1.9%
*W EXP 09/30/202$2.73M0.6%
*W EXP 06/30/205$1.25M0.3%
Portfolio Concentration
Top 3$424.09M92.7%
4–10$29.22M6.4%
11–25$4.15M0.9%
Top 3 weight
92.7%
Top 10 weight
99.1%
Voting Authority Distribution
Total shares with voting rights: 36.79M
Sole
Full voting authority
36.79M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole13
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings13
Rows:
INDIVIOR PLC
SOLEShares13.67M
TypeSH
Market value$325.32M
71.11%
Sole
13.67M
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares7.91M
TypeSH
Market value$79.73M
17.43%
Sole
7.91M
Shared
0.00
None
0.00
ARBUTUS BIOPHARMA CORP
SOLEShares8.28M
TypeSH
Market value$19.05M
4.16%
Sole
8.28M
Shared
0.00
None
0.00
META PLATFORMS INC
SOLEShares30K
TypeSH
Market value$8.61M
1.88%
Sole
30K
Shared
0.00
None
0.00
ODYSSEY MARINE EXPL INC
SOLEShares1.37M
TypeSH
Market value$4.94M
1.08%
Sole
1.37M
Shared
0.00
None
0.00
ESPERION THERAPEUTICS INC NE
SOLEShares2.94M
TypeSH
Market value$4.09M
0.89%
Sole
2.94M
Shared
0.00
None
0.00
HERTZ GLOBAL HLDGS INC
SOLEShares183.91K
TypeSH
Market value$3.38M
0.74%
Sole
183.91K
Shared
0.00
None
0.00
SONOS INC
SOLEShares171.17K
TypeSH
Market value$2.80M
0.61%
Sole
171.17K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares1.10M
TypeSH
Market value$2.73M
0.60%
Sole
1.10M
Shared
0.00
None
0.00
AMBAC FINL GROUP INC
SOLEShares187.57K
TypeSH
Market value$2.67M
0.58%
Sole
187.57K
Shared
0.00
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
SOLEShares232.20K
TypeSH
Market value$2.21M
0.48%
Sole
232.20K
Shared
0.00
None
0.00
HERTZ GLOBAL HLDGS INC
SOLEShares123.49K
TypeSH
Market value$1.25M
0.27%
Sole
123.49K
Shared
0.00
None
0.00
MALLINCKRODT PLC
SOLEShares585.60K
TypeSH
Market value$691.0K
0.15%
Sole
585.60K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
INDIVIOR PLCSOLE | ORD | 13.67M | SH | $325.32M 71.11% | 13.67M | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 7.91M | SH | $79.73M 17.43% | 7.91M | 0.00 | 0.00 |
ARBUTUS BIOPHARMA CORPSOLE | COM | 8.28M | SH | $19.05M 4.16% | 8.28M | 0.00 | 0.00 |
META PLATFORMS INCSOLE | CL A | 30K | SH | $8.61M 1.88% | 30K | 0.00 | 0.00 |
ODYSSEY MARINE EXPL INCSOLE | COM NEW | 1.37M | SH | $4.94M 1.08% | 1.37M | 0.00 | 0.00 |
ESPERION THERAPEUTICS INC NESOLE | COM | 2.94M | SH | $4.09M 0.89% | 2.94M | 0.00 | 0.00 |
HERTZ GLOBAL HLDGS INCSOLE | COM NEW | 183.91K | SH | $3.38M 0.74% | 183.91K | 0.00 | 0.00 |
SONOS INCSOLE | COM | 171.17K | SH | $2.80M 0.61% | 171.17K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | *W EXP 09/30/202 | 1.10M | SH | $2.73M 0.60% | 1.10M | 0.00 | 0.00 |
AMBAC FINL GROUP INCSOLE | COM NEW | 187.57K | SH | $2.67M 0.58% | 187.57K | 0.00 | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCSOLE | COM | 232.20K | SH | $2.21M 0.48% | 232.20K | 0.00 | 0.00 |
HERTZ GLOBAL HLDGS INCSOLE | *W EXP 06/30/205 | 123.49K | SH | $1.25M 0.27% | 123.49K | 0.00 | 0.00 |
MALLINCKRODT PLCSOLE | ORD SHS | 585.60K | SH | $691.0K 0.15% | 585.60K | 0.00 | 0.00 |